Lashkari, HP;
Nash, R;
Albanese, A;
Okoye, B;
Millar, R;
Pritchard-Jones, K;
(2013)
Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog.
Pediatric Blood & Cancer
, 60
(6)
E16 - E18.
10.1002/pbc.24382.
![[thumbnail of 24382_ftp.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
24382_ftp.pdf Download (1MB) |
Abstract
Sertoli-Leydig cell tumors are rare ovarian neoplasms. We report two unusual cases with bilateral SLCTs suggesting evidence of genetic predisposition and at high risk of recurrence. To reduce this risk, we exploited the use of GnRH analog to lower gondadotropin and potentially directly inhibit the tumors through expressed GnRH receptors. We used it as maintenance antitumor therapy for 2 years after completion of chemotherapy, to cover the period of risk for recurrence. Both patients remain in complete remission at >2 years after completing leuprorelin therapy. Of note, both patients carry DICER1 mutations, frequently found in pleuropulmonary blastoma syndrome.
| Type: | Article |
|---|---|
| Title: | Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1002/pbc.24382 |
| Publisher version: | http://dx.doi.org/10.1002/pbc.24382 |
| Language: | English |
| Additional information: | Wiley OnlineOpen article. Copyright © 2012 Wiley Periodicals, Inc |
| Keywords: | Antineoplastic Agents, Hormonal, Child, Female, Gonadotropin-Releasing Hormone, Humans, Leuprolide, Neoplasm Recurrence, Local, Ovarian Neoplasms, Sertoli-Leydig Cell Tumor |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1379259 |
Archive Staff Only
 |
View Item |
